A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers

Completed · Has a placebo group

Conditions studied: Healthy

In brief

The purpose of the study is to evaluate the difference in learning and performance measures associated with repeated use of an iPad video game (Akili Interactive's Project: EVO) in healthy elderly volunteers based on amyloid status.

Key facts

Study ID

NCT02265718

Run by

Pfizer

People needed

97

Starts

2014-09-01

Expected to finish

2016-05-01

Last updated by the study team

2019-06-05

Who can join

Age: 70 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy males and females between the ages of 70 and 80.
• Subjects must have BMI of 17.5 to 32 kg/m2 and total body weight > 110 pounds.
• Acceptable screening MRI and PET scans that pass quality control requirements.

You may not qualify if…

• Co-morbid diagnosis of clinically documented Alzheimer's disease; - Significant cognitive impairment;
• MMSE (mini mental state examination) score <26

Where it is running

• Collaborative Neuroscience Network, LLC — Long Beach, California, United States
• Broward Research Group — Hollywood, Florida, United States
• Miami Research Associates — South Miami, Florida, United States
• Jasper Clinic, Inc. — Kalamazoo, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.